Affiliation:
1. Division of Cardiology, Department of Medicine, University of Florida, Gainesville, FL 32611, USA
Abstract
Heart Failure (HF) and Atrial Fibrillation (AF) are common diseases which lead to significant morbidity and mortality. Each disease can be a challenge to treat clinically, especially when they present together. We performed a review of the literature including clinical trials, metanalyses,
and guidelines regarding the management of patients with HF and AF. This review describes the pathophysiologic mechanisms behind each disease state, their associated prognosis, and epidemiologic features. Strategies for prevention of stroke in patients with AF, including use of novel oral
anticoagulants as well as prevention of the development of AF are discussed. We review the medical and catheter-based therapies for AF and present an original algorithm for the management of AF in patients with HF.
Reference55 articles.
1. Type of atrial fibrillation and outcomes in patients with heart failure and reduced ejection fraction;Mogensen;J Am Coll Cardiol,2017
2. Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction;Sartipy;JACC Heart Fail,2017
3. Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins;Kotecha;J Am Coll Cardiol,2016
4. Effect of atrial fibrillation on mortality, stroke risk, and quality-of-life scores in patients with heart failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]);Cherian;Am J Cardiol,2017
5. The epicardial adipose inflammatory triad: coronary atherosclerosis, atrial fibrillation, and heart failure with a preserved ejection fraction;Packer;Eur J Heart Fail,2018
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献